“The first half of 2023 was productive for Yield10 as we demonstrated significant progress toward building our value chain for broadly commercializing Camelina as a platform crop to produce low-carbon intensity feedstock oil for the biofuel market,” said Oliver Peoples, president and CEO of Yield10. “We continue to engage with potential supply chain and customer prospects in the biofuel space, including ongoing discussions with Marathon Petroleum and Mitsubishi with the goal of finalizing Camelina oil offtake and investment agreements.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on YTEN:
- Yield10 Bioscience Announces Closing of $3.7 Million Public Offering
- Yield10 Bioscience Announces Second Quarter 2023 Financial Results
- Yield10 Bioscience to Announce Second Quarter 2023 Financial Results and Host a Conference Call on Monday, August 14, 2023
- Yield10 Bioscience prices 5.75M units at 65c in public offering
- Yield10 Bioscience Announces Pricing of $3.7 Million Public Offering
